Study: Cannabinoid Therapy Improves Dystonia in HD Patients | NORML
BOCHUM, GERMANY — Cannabinoid treatment is associated with improvements in dystonia in patients with early-onset Huntington’s disease, according to observational data published online ahead of print in the Journal of Huntington’s Disease. A team of investigators from Germany and Austria assessed the treatment of various synthetic or organic cannabinoid preparations – including Sativex, dronabinol, and nabilone – in seven HD patients who […]
Study: Cannabinoid Therapy Improves Dystonia in HD Patients | The Daily Chronic
Leave a Reply